Published in Cancer Prev Res (Phila) on April 28, 2009
Medical hyperspectral imaging: a review. J Biomed Opt (2014) 2.07
Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia. Cancer Prev Res (Phila) (2012) 1.33
Evaluation of a low-cost, portable imaging system for early detection of oral cancer. Head Neck Oncol (2010) 1.22
Fluorescence lifetime techniques in medical applications. Ann Biomed Eng (2012) 1.18
Spectral-Spatial Classification Using Tensor Modeling for Cancer Detection with Hyperspectral Imaging. Proc SPIE Int Soc Opt Eng (2014) 1.16
Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact. Cancer Prev Res (Phila) (2009) 1.12
Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci (2013) 1.09
Potential of optical coherence tomography for early diagnosis of oral malignancies. Expert Rev Anticancer Ther (2010) 1.08
Multimodal snapshot spectral imaging for oral cancer diagnostics: a pilot study. Biomed Opt Express (2013) 1.05
Emerging roles for multimodal optical imaging in early cancer detection: a global challenge. Technol Cancer Res Treat (2010) 1.03
Fluorescence lifetime imaging and reflectance confocal microscopy for multiscale imaging of oral precancer. J Biomed Opt (2013) 1.03
Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol (2010) 1.00
Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era. Periodontol 2000 (2011) 0.99
A dynamic oral cancer field: unraveling the underlying biology and its clinical implication. Am J Surg Pathol (2009) 0.97
Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer. Cancer Prev Res (Phila) (2014) 0.92
Recovery of intrinsic fluorescence from single-point interstitial measurements for quantification of doxorubicin concentration. Lasers Surg Med (2013) 0.88
Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasia. J Biomed Opt (2011) 0.88
Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Otolaryngol Head Neck Surg (2011) 0.87
Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa. Transl Oncol (2012) 0.87
High-Resolution Optical Imaging of Benign and Malignant Mucosa in the Upper Aerodigestive Tract: An Atlas for Image-Guided Surgery. ISRN Minim Invasive Surg (2012) 0.87
Incidental detection of an occult oral malignancy with autofluorescence imaging: a case report. Head Neck Oncol (2009) 0.85
In vivo wide-field reflectance/fluorescence imaging and polarization-sensitive optical coherence tomography of human oral cavity with a forward-viewing probe. Biomed Opt Express (2015) 0.84
Diagnostic accuracy of diffuse reflectance imaging for early detection of pre-malignant and malignant changes in the oral cavity: a feasibility study. BMC Cancer (2013) 0.83
Emerging strategies for the early detection and prevention of head and neck squamous cell cancer. J Cell Physiol (2012) 0.83
Optical diagnostics in the oral cavity: an overview. Oral Dis (2010) 0.82
Vital-dye-enhanced multimodal imaging of neoplastic progression in a mouse model of oral carcinogenesis. J Biomed Opt (2013) 0.80
Wide-field spectral imaging of human ovary autofluorescence and oncologic diagnosis via previously collected probe data. J Biomed Opt (2012) 0.79
Advances in bio-optical imaging for the diagnosis of early oral cancer. Pharmaceutics (2011) 0.79
Advances in optical adjunctive AIDS for visualisation and detection of oral malignant and potentially malignant lesions. Int J Dent (2013) 0.79
A quantitative diagnostic method for oral mucous precancerosis by Rose Bengal fluorescence spectroscopy. Lasers Med Sci (2012) 0.78
Low-cost, portable optical imaging systems for cancer diagnosis. Conf Proc IEEE Eng Med Biol Soc (2010) 0.77
Use of endoscopy with narrow-band imaging system in detecting squamous cell carcinoma in oral chronic non-healing ulcers. Clin Oral Investig (2013) 0.77
Techniques for early diagnosis of oral squamous cell carcinoma: Systematic review. Med Oral Patol Oral Cir Bucal (2015) 0.75
Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions. Sci Rep (2016) 0.75
Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct. J Maxillofac Oral Surg (2014) 0.75
Biopsy Diagnosis of Oral Carcinoma by the Combination of Morphological and Spectral Methods Based on Embedded Relay Lens Microscopic Hyperspectral Imaging System. J Med Biol Eng (2015) 0.75
Autofluorescence based diagnostic techniques for oral cancer. J Pharm Bioallied Sci (2015) 0.75
Time-resolved fluorescence spectroscopy for clinical diagnosis of actinic cheilitis. Biomed Opt Express (2016) 0.75
A novel multimodal optical imaging system for early detection of oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol (2015) 0.75
Automated algorithm for actinic cheilitis diagnosis by wide-field fluorescence imaging. J Med Imaging (Bellingham) (2016) 0.75
A study of diagnostic criteria established for two oral mucous diseases by HMME-fluorescence spectroscopy. Lasers Med Sci (2015) 0.75
Prospective Evaluation of Multi-modal Optical Imaging with Automated Image Analysis to Detect Oral Neoplasia In Vivo. Cancer Prev Res (Phila) (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med (1998) 20.81
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem (1996) 5.56
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res (2003) 5.04
Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol (2007) 4.52
Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest Endosc (2006) 3.60
Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst (1998) 3.17
Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res (2006) 2.73
Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt (2006) 2.58
Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt (2008) 2.03
The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol (2005) 1.94
Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res (2008) 1.92
In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol (1997) 1.71
Second primary tumors in patients with oral cancer. Cancer (1992) 1.51
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst (2001) 1.45
Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys (1989) 1.34
Does autofluorescence imaging videoendoscopy system improve the colonoscopic polyp detection rate?--a pilot study. Am J Gastroenterol (2008) 1.33
Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer (2000) 1.27
Clinical study for classification of benign, dysplastic, and malignant oral lesions using autofluorescence spectroscopy. J Biomed Opt (2004) 1.16
Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg (2007) 1.13
Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence. Head Neck (2004) 1.11
Low-cost, multimodal, portable screening system for early detection of oral cancer. J Biomed Opt (2008) 1.10
Oral premalignancy: new methods of detection and treatment. Curr Oncol Rep (2006) 1.09
Detection and localization of early lung cancer by imaging techniques. Chest (1993) 1.08
Intraoral squamous cell carcinoma. Epidemiologic patterns in Connecticut from 1935 to 1985. Cancer (1990) 1.05
Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol (2003) 1.04
Visualization and other emerging technologies as change makers for oral cancer prevention. Ann N Y Acad Sci (2007) 1.03
Laser-induced fluorescence imaging in localization of head and neck cancers. Ann Otol Rhinol Laryngol (1998) 0.99
A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol (2004) 0.99
Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt (2008) 0.96
Optimal visual perception and detection of oral cavity neoplasia. IEEE Trans Biomed Eng (2003) 0.93
Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol (2000) 0.80
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov (2011) 7.57
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell (2004) 7.22
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys (2002) 6.82
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol (2014) 5.80
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. J Clin Oncol (2012) 4.77
Dose escalation methods in phase I cancer clinical trials. J Natl Cancer Inst (2009) 4.36
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res (2003) 4.22
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet (2003) 3.61
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res (2012) 3.48
Retracted The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med (2004) 3.22
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol (2008) 3.16
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol (2012) 3.08
Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila) (2012) 3.03
Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy. Opt Express (2007) 3.01
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab (2008) 2.89
Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center. Clin Trials (2009) 2.79
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst (2012) 2.79
Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab (2010) 2.74
Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int J Cancer (2008) 2.72
Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine. Clin Trials (2008) 2.71
Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer (2013) 2.69
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst (2006) 2.61
Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res (2007) 2.61
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse. Clin Cancer Res (2010) 2.56
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. Int J Radiat Oncol Biol Phys (2012) 2.55
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol (2002) 2.52
High-resolution imaging in Barrett's esophagus: a novel, low-cost endoscopic microscope. Gastrointest Endosc (2008) 2.51
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov (2013) 2.49
Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol (2009) 2.48
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies. J Clin Oncol (2012) 2.48
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets (2012) 2.42
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol (2007) 2.40
Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A (2007) 2.38
Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer. J Clin Oncol (2012) 2.31
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials. Cancer Res (2012) 2.27
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol (2009) 2.15
Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2012) 2.14
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res (2006) 2.13
Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt (2002) 2.10
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell (2012) 2.04
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer (2006) 2.04
Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt (2008) 2.03
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) (2009) 1.99
Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A (2008) 1.98
Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt (2003) 1.96
Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol (2002) 1.94
Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res (2008) 1.92
Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. J Biomed Opt (2007) 1.90
Portable, battery-operated, low-cost, bright field and fluorescence microscope. PLoS One (2010) 1.88
High-resolution fiber-optic microendoscopy for in situ cellular imaging. J Vis Exp (2011) 1.88
Optical imaging for cervical cancer detection: solutions for a continuing global problem. Nat Rev Cancer (2008) 1.84
Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue. Acad Radiol (2002) 1.84
A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer. Cancer Prev Res (Phila) (2012) 1.84
In vivo fiber-optic confocal reflectance microscope with an injection-molded plastic miniature objective lens. Appl Opt (2005) 1.83
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. PLoS One (2011) 1.80
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila) (2010) 1.80
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. J Natl Cancer Inst (2007) 1.79
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol (2003) 1.78
Fiber-optic confocal microscope using a MEMS scanner and miniature objective lens. Opt Express (2007) 1.78
Noninvasive imaging of oral neoplasia with a high-resolution fiber-optic microendoscope. Head Neck (2011) 1.77
Nano-bio-chip sensor platform for examination of oral exfoliative cytology. Cancer Prev Res (Phila) (2010) 1.76
Evaluation of quantitative image analysis criteria for the high-resolution microendoscopic detection of neoplasia in Barrett's esophagus. J Biomed Opt (2010) 1.76
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst (2003) 1.75
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol (2009) 1.74
Mortality risk from squamous cell skin cancer. J Clin Oncol (2005) 1.74
Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. J Pathol (2011) 1.72
Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system. Cancer Prev Res (Phila) (2009) 1.71
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila) (2011) 1.70
Microanatomical and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol (2003) 1.69
Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol (2013) 1.68
Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe. Appl Opt (2008) 1.68
Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer (2002) 1.67
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol (2009) 1.66
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med (2010) 1.62
Plasmonic nanosensors for imaging intracellular biomarkers in live cells. Nano Lett (2007) 1.62
Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer (2009) 1.61